EmployblEmploybl logo
employbl
AmbAgon Therapeutics logo

AmbAgon Therapeutics Funding & Investors

AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.

ambagontx.com

Total Amount Raised: $85,000,000

AmbAgon Therapeutics Funding Rounds

  • Series A

    $85,000,000

    Series A Investors

    Nextech Invest
    AbbVie Biotech Ventures
    Droia Ventures
    INKEF Capital
    MRL Ventures Fund
    Surveyor Capital
    Ra Capital Management
    Mission BioCapital
Funding info provided by Diffbot.